Sound Pharmaceuticals is pleased to announce that the pivotal Phase 3 clinical trial involving SPI-1005, a novel anti-inflammatory compound (ebselen), for the treatment of Meniere's Disease (STOPMD-3) ...

Sstudy identifies how somatosensory factors, including snoring and sleep apnea, contribute to tinnitus loudness increases ...